INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
InfuSystem Holdings, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$13.74+0.34 (+2.54%)
Close on Oct 19, 2026
- Market cap
- $287.44M
- P/E (TTM)
- 33.5
- Dividend yield
- –
InfuSystem Holdings, Inc revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient Services and Device Solutions | $113.19M | $112.42M | $113.08M | $110.15M | $109.14M | $107.60M | $106.30M | $105.70M | $102.56M | $100.40M | $98.74M | – | 79.0% | +3.7% |
| Patient Services | $91.13M | $87.86M | $86.53M | $85.42M | $83.83M | $82.56M | $80.38M | $78.78M | $77.29M | $76.36M | $76.54M | $75.00M | 63.6% | +8.7% |
| Device Solutions | $59.20M | $61.49M | $64.10M | $63.04M | $63.51M | $62.44M | $61.74M | $61.13M | $58.81M | $57.72M | $55.83M | $54.36M | 41.3% | -6.8% |
By product or service
By region
From the segment and revenue-disaggregation notes of InfuSystem's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.